Elucidating the exact pharmacological mechanism of action (MOA) of naturally transpiring compounds is usually challenging. While Tarselli et al. (60) developed the very first de novo artificial pathway to conolidine and showcased this naturally transpiring compound proficiently suppresses responses to both equally chemically induced and inflammation-derived pain, the pharmacologic https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers